PDL BioPharma Inc. (PDLI) Declined -5.28% or -0.2 To Price $3.59 On Friday

PDL BioPharma Inc. (PDLI) declined -5.28% or -0.2 to $3.59. It is close to 1.29 million shares traded, which is 71.06% compare to the average total volume 1.82 million. The market cap of PDLI is $459.91 million. The year to date change is 24.96%. The 52 week price range is from $2.25 to $3.82. Price of PDLI have changed 6.76% during last week. It have changed 13.81% over last month, 31.60% over last 3 months, 66.23% over last 6 months and 28.04% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PDLI is 3.38. It is -5.85% below current price. The 200-day Moving Averages for PDLI is 2.80. It is -22.01% below current price. The 52-week High is 3.82. It is 6.41% from the current price. The 52-week Low is 2.25. It is -37.33% from current price.

There are some statistics of PDLI. It is has market cap $459.91 million. The share outstanding is 128.11 million. The average volume is 1.82 million. The percent of top 15 Institution holding is 130.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PDLI is -8.74%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PDLI is -6.24%.


Share this post